Mazor Robotics Financial News

Mazor Robotics Reports Record Fourth Quarter and Full Year 2016 Results

– Full Year Revenue Increased 39% to $36.4 Million; Record 62 System Orders Received in 2016 –

– Fourth Quarter Revenue increased 59% to $14.0 Million –

– Full Year Recurring Revenue Increased 32%; Fourth Quarter Recurring Revenue Increased 29% –

– Total Procedures Performed to Date Surpassed 23,000 –

– Year-end Backlog of 21 Systems in the U.S. –

– Conference Call Today at 8:30 AM ET (3:30PM IST) –

CAESAREA, Israel – February 16, 2017 – Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a pioneer and a leader in the field of surgical guidance systems, reported record revenue for the fourth quarter and full year ended December 31, 2016. As previously announced, the Company received purchase orders for 21 systems in the fourth quarter and ended the year with a backlog of 21 systems, including 18 Mazor X systems, its transformative platform for spine surgeries, which was commercially launched in October.

“Our record performance in the fourth quarter and success throughout the year reinforces 2016 as a strategic turning point for the Company,” commented Ori Hadomi, Chief Executive Officer.  “We have greatly enhanced our leadership position in the spine market with the implementation of the Medtronic co-marketing and co-promotional agreement and the launch of the transformational Mazor X system.  While our systems order growth is impressive, our high utilization rate and recurring revenue growth illustrates the benefits Mazor is bringing to both surgeon and patient. With a strong backlog, we enter 2017 with momentum to continue our growth.

FOURTH QUARTER 2016 FINANCIAL RESULTS ON IFRS BASIS (“GAAP”)

Revenue for the three months ended December 31, 2016 increased 59% to $14.0 million compared to $8.8 million in the year-ago fourth quarter. U.S. revenue increased 88% to $12.6 million compared to $6.7 million in the year-ago fourth quarter, as the Company recognized revenue from 13 Mazor X and two Renaissance systems, compared to ten Renaissance systems in the year-ago fourth quarter. The Company ended the quarter with a backlog of 21 systems; revenue from these systems is expected to be recorded in 2017, generally, when the systems are supplied. International revenue was $1.4 million compared to $2.1 million in the year-ago fourth quarter, as the Company recognized revenue from three Renaissance systems, compared to four Renaissance systems in the year-ago fourth quarter. Recurring revenue from system kit sales, services and other increased 29% to $4.5 million in the fourth quarter of 2016, compared to $3.5 million in the year-ago fourth quarter. The increase is attributed to high utilization rates and increase of the install base.

The Company’s gross margin for the three months ended December 31, 2016 was 70.5% compared to 78.0% in the year-ago fourth quarter. The decrease is attributed mainly to discounted price to our distribution partner, Medtronic, and the higher manufacturing costs of the Mazor X, compared to the Renaissance system. Total operating expenses were $14.2 million compared to $9.8 million in the year-ago fourth quarter, primarily reflecting the Company’s increased investments in sales and marketing activities. Operating loss was $4.3 million compared to an operating loss of $2.9 million in the year-ago fourth quarter. Net loss for the fourth quarter of 2016 was $4.3 million, or $0.09 per share, compared to a net loss of $2.9 million, or $0.07 per share, for the year-ago fourth quarter.

Cash used in operating activities was $1.9 million compared to $4.3 million used in last year’s fourth quarter. The decrease is mainly due to high collection from customers, offset by higher payments to suppliers. As of December 31, 2016, cash, cash equivalents and investments totaled $61.8 million.

FOURTH QUARTER 2016 FINANCIAL RESULTS ON NON-GAAP BASIS

The tables below include reconciliation of the Company’s GAAP results to non-GAAP results. The reconciliation relates to non-cash expenses in the amount of $1.1 million with respect to amortization of intangible assets and to share-based expenses recorded in the fourth quarter of 2016. On a non-GAAP basis, the net loss in the fourth quarter of 2016 was $3.1 million, or $0.07 per share, compared to $2.1 million, or $0.05 per share, for the year-ago fourth quarter.

FULL YEAR ENDED DECEMBER 31, 2016 FINANCIAL RESULTS ON IFRS BASIS (“GAAP”)

 

For the full year ended December 31, 2016, revenue increased 39% to $36.4 million compared to $26.1 million for the full year ended December 31, 2015. U.S. revenue increased 51% to $30.7 million compared to $20.3 million in the full year ended December 31, 2015, as the Company recognized revenue from 30 systems, compared to 16 systems in the full year ended December 31, 2015. International revenue was $5.7 million compared to $5.8 million in the full year ended December 31, 2015, as the Company recognized revenue from 11 Renaissance systems, compared to eight Renaissance systems in the full year ended December 31, 2015. Recurring revenue totaled $16.8 million compared to $12.7 million for the full year ended December 31, 2015. The growth in recurring revenue is attributed to the increase of the install base of the Company’s Renaissance system in the U.S. and globally.

Gross margin for the full year ended December 31, 2016 was 71.6% compared to 77.7% for the full year ended December 31, 2015. The decrease is mainly attributed to the discounted price to our distribution partner, the lower price of Renaissance (effective Q3 2016) and the higher manufacturing costs of the Mazor X, compared to the Renaissance system. Total operating expenses were $45.1 million compared to $35.6 million in the full year ended December 31, 2015, primarily reflecting the Company’s increased investments in sales and marketing activities. Operating loss was $19.0 million compared to an operating loss of $15.3 million in the full year ended December 31, 2015. Net loss for the full year ended December 31, 2016 was $18.7 million, or $0.42 per share, compared to $15.4 million, or $0.36 per share for the full year ended December 31, 2015.

Cash used in operating activities was $10.1 million compared to $11.6 million used in the full year ended December 31, 2015. The decrease is mainly due to high collection from customers.

FULL YEAR ENDED DECEMBER 31, 2016 FINANCIAL RESULTS ON NON-GAAP BASIS

 

The tables below include reconciliation of the Company’s GAAP results to non-GAAP results. The reconciliation relates to non-cash expenses in the amount of $2.6 million with respect to capitalization of research and development costs, amortization of intangible assets and to share-based expenses recorded in 2016. On a non-GAAP basis, the net loss for the full year ended December 31, 2016 was $16.1 million, or $0.36 per share, compared to a net loss of $12.3 million, or $0.29 per share, for the full year ended December 31, 2015.

CONFERENCE CALL INFORMATION

 

The Company will host a conference call to discuss these results on February 16, 2017 at 8:30am ET (3:30 PM IST). Investors within the United States interested in participating are invited to call 888-312-3052. Participants in Israel can use the toll free dial-in number 1 80 924 5905. All other international participants can use the dial-in number 719-457-2695.

A replay of the event will be available for two weeks following the conclusion of the call. To access the replay, callers in the United States can call 1-866-375-1919 and reference the Replay Access Code: 2887710. All international callers can dial +1 719-457-0820, using the same Replay Access Code. To access the webcast, please visit www.mazorrobotics.com and select ‘Investor Relations.’

 

Use of Non-GAAP Measures

 

In addition to disclosing financial results calculated in accordance with generally accepted accounting principles in conformity with International Financial Reporting Standards (GAAP), this press release contains Non-GAAP financial measures for gross profit, operating expenses, operating loss, net loss and basic and diluted earnings per share that exclude the effects of capitalization of research and development costs, non-cash expense of amortization of intangible assets and share-based expenses. Management believes that these non-GAAP financial measures provide meaningful supplemental information regarding the Company’s performance that enhances management’s and investors’ ability to evaluate the Company’s net income and earnings per share and to compare them to historical net income and earnings per share.

The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Management uses both GAAP and non-GAAP measures when operating and evaluating the Company’s business internally and therefore decided to make these non-GAAP adjustments available to investors.

About Mazor

Mazor Robotics (TASE: MZOR; NASDAQGM: MZOR) believes in healing through innovation by developing and introducing revolutionary technologies and products aimed at redefining the gold standard of quality care. Mazor Robotics Guidance System enables surgeons to conduct spine and brain procedures in an accurate and secure manner. For more information, please visit www.MazorRobotics.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. Any statements in this release about future expectations, plans or prospects for the Company, including without limitation, statements regarding the Company’s expectations for 2017, the amount of and timing of recording of additional revenue from backlog, and other statements containing the words “believes,” “anticipates,” “plans,” “expects,” “will” and similar expressions are forward-looking statements. These statements are only predictions based on Mazor’s current expectations and projections about future events. There are important factors that could cause Mazor’s actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements. Those factors include, but are not limited to, the impact of general economic conditions, competitive products, product demand and market acceptance risks, reliance on key strategic alliances, fluctuations in operating results, and other factors indicated in Mazor’s filings with the Securities and Exchange Commission (SEC) including those discussed under the heading “Risk Factors” in Mazor’s annual report on Form 20-F filed with the SEC on May 2, 2016 and in subsequent filings with the SEC. For more details, refer to Mazor’s SEC filings. Mazor undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or to changes in our expectations, except as may be required by law.

U.S. Contacts: EVC Group

Michael Polyviou/Doug Sherk – Investors

This email address is being protected from spambots. You need JavaScript enabled to view it.; This email address is being protected from spambots. You need JavaScript enabled to view it.

212.850.6020; 646-445-4800


 

Mazor Robotics Ltd.

                   CONSOLIDATED STATEMENT OF PROFIT OR LOSS

(U.S. Dollars in thousands, except per share data)

 

      Twelve month period     Three month period
      ended December 31,     ended December 31,
             
      2016

(Unaudited)

    2015

(Audited)

    2016

(Unaudited)

    2015

(Unaudited)

Revenue     $ 36,379     $ 26,096     $ 14,043     $ 8,818
                                 
Cost of revenue       10,330       5,827       4,148       1,940
                                 
Gross profit       26,049       20,269       9,895       6,878
                                 
Operating costs and expenses:                                
Research and development       5,736       6,324       1,709       1,585
Selling and marketing       33,637       24,947       10,856       7,115
General and administrative       5,697       4,305       1,625       1,072
Total operating costs and expenses       45,070       35,576       14,190       9,772
                                 
Loss from operations       (19,021)       (15,307)       (4,295)       (2,894)
                                 
Financing income, net       397       135       52       43
                                 
Loss before taxes on income       (18,624)       (15,172)       (4,243)       (2,851)
                                 
Income tax expense       44       213       23       59
                                 
Net loss     $ (18,668)     $ (15,385)     $ (4,266)     $ (2,910)
                                 
Net loss per share – Basic and diluted     $ (0.42)     $ (0.36)     $ (0.09)     $ (0.07)
                                 
Weighted average common shares outstanding – Basic and diluted       44,881       42,284       47,560       42,349

 

 


 

Mazor Robotics Ltd.

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION AS OF

(U.S. Dollars in thousands)

 

  December 31,   December 31,
  2016   2015
  (Unaudited)   (Audited)
Current assets          
Cash and cash equivalents $ 14,954   $ 13,519
Short-term investments   37,862     21,687
Trade receivables   8,225     5,002
Other current assets   1,728     1,420
Inventory   4,715     2,777
Total current assets   67,484     44,405
           
Non-current assets          
Long-term investments   9,017     5,023
Property and equipment, net   3,615     1,432
Intangible assets, net   2,258    
Other non-current assets   351     110
Total non-current assets   15,241     6,565
           
Total assets $ 82,725   $ 50,970
           
Current liabilities          
Trade payables $ 5,018   $ 2,219
Deferred revenue   4,031     1,221
Other current liabilities   8,462     4,831
Total current liabilities   17,511     8,271
           
Non-current liabilities          
Employee benefits   325     299
Total non-current liabilities   325     299
Total liabilities   17,836     8,570
           
Equity          
Share capital   124     110
Share premium   174,647     136,107
Amounts allocated to share options       77
Capital reserve for share-based payment transactions   9,859     7,179
Foreign currency translation reserve   2,119     2,119
Accumulated loss   (121,860)     (103,192)
Total equity   64,889     42,400
           
Total liabilities and equity $ 82,725   $ 50,970

 


Mazor Robotics Ltd.
CONSOLIDATED CASH FLOW STATEMENTS
(U.S. Dollars in thousands)

    Twelve month period     Three month period
    ended December 31,     ended December 31,
    2016

(Unaudited)

    2015

(Audited)

    2016

(Unaudited)

    2015

(Unaudited)

Cash flows from operating activities:                              
Loss for the period   $ (18,668)     $ (15,385)     $ (4,266)     $ (2,910)
Adjustments:                              
Depreciation and amortization     822       527       346       129
Gain on sale of property and equipment     (6)                  
Finance (income) expenses, net     (275)       (207)       38       30
Share-based expenses     4,439       3,091       1,061       832
Income tax expense     44       213       23       59
      5,024       3,624       1,468       1,050
                               
Change in inventory     (1,938)       273       (650)       (146)
Change in trade and other accounts receivable     (3,512)       (2,408)       (5,588)       (3,517)
Change in prepaid lease fees     (20)       6       (2)       4
Change in trade and other accounts payable     8,723       2,217       7,088       1,064
Change in employee benefits     26       21       (13)       9
      3,279       109       835       (2,586)
                               
Interest received     301       194       66       145
Income tax paid     (38)       (114)             (30)
      263       80       66       115
                               
Net cash used in operating activities     (10,102)       (11,572)       (1,897)       (4,331)
                               
Cash flows from investing activities:                              
Proceeds from (Purchase of ) short-term investments, net     (11,094)       9,816       523       (3,929)
Purchase of long-term investments     (9,823)       (7,538)       (917)       (60)
Proceeds from sale of long-term investments     748       992       250      
Purchase of property and equipment     (2,361)       (702)       (626)       (266)
Capitalization of development costs     (1,902)             (385)      
Net cash provided by (used in) investing activities     (24,432)       2,568       (1,155)       (4,255)
                               
Cash flows from financing activities:                              
Proceeds from issuance of ADR’s, net     31,416                  
Proceeds from exercise of share options by employees and                              
service providers     4,100       370       513       10
Proceeds from exercise of warrants by investors     481                  
Net cash provided by financing activities     35,997       370       513       10
                               
Net increase (decrease) in cash and cash equivalents     1,463       (8,634)       (2,539)       (8,576)
Cash and cash equivalents at the beginning of the period     13,519       22,255       17,597       22,283
Effect of exchange rate differences on balances of                              
cash and cash equivalents     (28)       (102)       (104)       (188)
Cash and cash equivalents at the end of the period   $ 14,954     $ 13,519     $ 14,954     $ 13,519
                               
Supplementary cash flows information:                              
Purchase of property and equipment on credit   $ (566)     $     $ (566)     $
Issuance costs in credit   $ (20)     $     $ (20)     $

 

 

 

Mazor Robotics Ltd.

RECONCILIATIONS OF GAAP TO NON-GAAP FINANCIAL MEASURES

(U.S. Dollars in thousands, except per share data)

(UNAUDITED)

    Twelve month period     Three month period
    ended December 31,     ended December 31,
    2016     2015     2016     2015
GAAP gross profit   $ 26,049     $ 20,269     $ 9,895     $ 6,878
Amortization of intangible assets     74             74      
Share-based expense     207       130       37       39
Non-GAAP gross profit   $ 26,330     $ 20,399     $ 10,006     $ 6,917
GAAP gross profit as percentage of revenues     71.6%       77.7%       70.5%       78.0%
Non-GAAP gross profit as percentage of revenues     72.4%       78.2%       71.3%       78.4%
                               
GAAP operating expenses   $ 45,070     $ 35,576     $ 14,190     $ 9,772
Share-based expenses:                              
   Research and development     783       475       88       131
   Selling and marketing     2,435       1,575       463       456
   General and administrative     1,444       911       473       206
Research and development – capitalization     (2,332)                  
Non-GAAP operating expenses   $ 42,740     $ 32,615     $ 13,166     $ 8,979
                               
GAAP operating loss   $ (19,021)     $ (15,307)     $ (4,295)     $ (2,894)
                               
Non-GAAP operating loss   $ (16,410)     $ (12,216)     $ (3,160)     $ (2,062)
                               
GAAP net loss   $ (18,668)     $ (15,385)     $ (4,266)     $ (2,910)
Share-based expenses     4,869       3,091       1,061       832
Research and development – capitalization     (2,332)                  
Amortization of intangible assets     74             74      
Non-GAAP net loss   $ (16,057)     $ (12,294)     $ (3,131)     $ (2,078)
                               
GAAP basic and diluted loss per share   $ (0.42)     $ (0.36)     $ (0.09)     $ (0.07)
                               
Non-GAAP basic and diluted loss per share   $ (0.36)     $ (0.29)     $ (0.07)     $ (0.05)

 

 

 

Mazor Robotics' Investor Section Links

Below are quick links to what you may be looking for, if you are unable to find what you are looking for please contact us.

Corporate Governance

In this section you will find our rules, practices and processes by which Mazor is directed and controlled.

Regulatory Filings

In this section you will find links to our regulatory filings current with the SEC. TASE filings can be located on the Tel-Aviv Stock Exchange.

Conferences & Calls

In this section you will be able to listen to or view any of the transcripts from Mazor Robotics' Conferences or Investor relations calls.

Analyst Coverage

In this section you will find a list of Analysts whom currently write research reports on Mazor Robotics.

Financial Reports

In this section you can view recent Mazor Robotics' financial reports. Reports are downloadable in PDF formats.

Shareholder Meetings

In this section you can view Mazor Robotics' Shareholder Meeting reports. Reports are downloadable in PDF formats.

Stock Information

Mazor Robotics is traded on both the TASE and NASDAQ markets. In this section you may view delayed NASDAQ stock information.

Investor Press Releases

In this section you may view all Mazor Robotics' press releases that have been issued by our corporate offices.

Investor Contacts

In this section you will find our Investor contacts. If you have any questions please contact one of the following people.

Investor Presentation

In this section you will be able to view the individual presentations from Mazor Robotics’ executive team.

Latest News

15
Sep2017

Mazor Robotics Announces Closing of...

CAESAREA, Israel--(BUSINESS WIRE)-- Mazor Robotics Ltd. (TASE:MZOR) (NASDAQGM:MZOR), a pioneer and a leader in the field of...

05
Sep2017

Mazor Robotics to Present at...

CAESAREA, Israel--(BUSINESS WIRE)-- Mazor Robotics Ltd. (TASE:MZOR)(NASDAQGM:MZOR), a pioneer and a leader in the field of surgical...

30
Aug2017

Mazor Robotics and Medtronic Enter...

Register for the Conference Call CAESAREA, Israel – August 30, 2017 – Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM:...

01
Aug2017

Mazor Robotics Reports Record Second...

- Recurring Revenues Increased 50% Year-over-Year - - Conference Call Today at 8:30 AM EDT (3:30PM IDT) - ...

19
Jul2017

Mazor Robotics to Report Second...

Conference Call Scheduled for 8:30am EDT on Tuesday, August 1st CAESAREA, Israel, July 19, 2017 – Mazor...

06
Jul2017

Mazor Robotics Received 19 System...

CAESAREA, Israel--(BUSINESS WIRE (http://www.businesswire.com/))-- Mazor Robotics Ltd. (TASE:MZOR; NASDAQGM:MZOR), a pioneer and a leader in the...

20
Apr2017

Mazor Robotics to Report First...

Conference Call Scheduled for 8:30am ET on Wednesday, May 10th CAESAREA, Israel–(BUSINESS WIRE (http://www.businesswire.com/))– Mazor Robotics Ltd. (TASE:MZOR;...

12
Apr2017

Mazor Robotics Receives FDA Clearance...

CAESAREA, Israel – April 12, 2017 – Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a pioneer and...

05
Apr2017

Mazor Robotics Expects to Report...

CAESAREA, Israel–(BUSINESS WIRE)– Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a pioneer and a leader in the...

16
Feb2017

Mazor Robotics Reports Record Fourth...

CAESAREA, Israel – February 16, 2017 – Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a pioneer and...

«
»

Latest Tweet


#Spine Surgeon in Thailand Successfully Completes First International #MazorRobotics #PROlat™ Case https://t.co/GMYdguFeEF
Follow Mazor Robotics on Twitter